Estrogens improve differentiation of facioscapulohumeral muscular dystrophy myoblasts by antagonizing DUX4 activity

Autor: Emanuela Teveroni1, 2, Marsha Pellegrino1, Sabrina Sacconi3, 4, Patrizia Calandra1, Isabella Cascino1, Stefano Farioli-Vecchioli1, Roberta Morosetti5, Giorgio Tasca6, Enzo Ricci5, Giuliana Galluzzi1, Alfredo Pontecorvi2, Marco Crescenzi8, Giancarlo Deidda1, Fabiola Moretti1, 9

Publikováno v: FSH Society Facioscapulohumeral Muscular Dystrophy [FSHD] 2016 International Research Consortium & Research Planning Meetings, Boston MA, USA, 10-11 November 2016
info:cnr-pdr/source/autori:Emanuela Teveroni1,2, Marsha Pellegrino1, Sabrina Sacconi3,4, Patrizia Calandra1, Isabella Cascino1, Stefano Farioli-Vecchioli1, Roberta Morosetti5, Giorgio Tasca6, Enzo Ricci5, Giuliana Galluzzi1, Alfredo Pontecorvi2, Marco Crescenzi8, Giancarlo Deidda1#, Fabiola Moretti1,9#/congresso_nome:FSH Society Facioscapulohumeral Muscular Dystrophy [FSHD] 2016 International Research Consortium & Research Planning Meetings/congresso_luogo:Boston MA, USA/congresso_data:10-11 November 2016/anno:2016/pagina_da:/pagina_a:/intervallo_pagine

Facioscapulohumeral muscular dystrophy (FSHD) is characterized by extreme variability in symptoms with females being less severely affected than males and presenting a higher proportion of asymptomatic carriers. Gender factors involved in the disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::dc65d9590183f1a3939a061bdeb0db1f
http://www.cnr.it/prodotto/i/363483